Vyvanse and Estradiol drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Vyvanse (lisdexamfetamine dimesylate) and Estradiol (estradiol). Common drug interactions include insomnia among females and fatigue among males.
The phase IV clinical study analyzes what interactions people have when they take Vyvanse and Estradiol. It is created by eHealthMe based on reports of 61 people who take the same drugs from the FDA, and is updated regularly.
What is Vyvanse?
Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 35,872 Vyvanse users. Check the latest studies of Vyvanse.
What is Estradiol?
Estradiol has active ingredients of estradiol. It is often used in menopause. eHealthMe is studying from 18,987 Estradiol users. Check the latest studies of Estradiol.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
61 people who take Vyvanse and Estradiol together, and have interactions are studied.

What are the common drug interactions of Vyvanse and Estradiol, by gender? *:
female:
- Insomnia (sleeplessness)
- Restless legs syndrome (a powerful urge to move your legs)
- Ankle fracture
- Breast cancer
- Heart rate increased
- Hypoaesthesia (reduced sense of touch or sensation)
- Pain in extremity
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Sinusitis (inflammation of sinus)
- Sleep disorder
male:
- Fatigue (feeling of tiredness)
- Impaired healing
What are the common drug interactions of Vyvanse and Estradiol, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Haemorrhage (bleeding)
- Pruritus (severe itching of the skin)
20-29:
n/a
30-39:
- Fatigue (feeling of tiredness)
- Age-related macular degeneration
- Anxiety
- Colitis ulcerative (inflammation of colon with ulcer)
- Retinal pigmentation (pigmentation of retina)
- Impaired healing
- Apathy
- Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
- Autoimmune thyroiditis (form of thyroiditis associated with an autoimmune disease)
- Blood cholesterol increased
40-49:
- Local swelling (swelling at the site of some application of substance or injury)
- Muscle rupture (tear in muscle)
- Muscle spasms (muscle contraction)
- Muscular weakness (muscle weakness)
- Neuroma (tumour of nerve tissue)
- Neuropathy peripheral (surface nerve damage)
- Nocturia (the need to get up in the night to urinate)
- Oedema mouth (swelling of mouth)
- Oral herpes (viral infection of mouth)
- Pain
50-59:
- Breast cancer
- Sinusitis (inflammation of sinus)
- Vertigo
- Abdominal discomfort
- Akathisia (a movement disorder characterized by a feeling of inner restlessness)
- Arthropathy
- Asthma
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Cystitis interstitial (unknown cause characterized by bladder pain)
- Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
60+:
- Pain
- Constipation
- Weight increased
- Dehydration (dryness resulting from the removal of water)
- Multi-vitamin deficiency (lack of vitamins)
- Blood pressure increased
- Hospitalisation
- Knee arthroplasty
- Dyspepsia (indigestion)
- Headache (pain in head)
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 22 people, 36.07%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 17 people, 27.87%
- Drowsiness: 14 people, 22.95%
- Depression: 8 people, 13.11%
- Immunodeficiency Common Variable: 5 people, 8.20%
- Stress And Anxiety: 4 people, 6.56%
- High Blood Pressure: 4 people, 6.56%
- Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 4 people, 6.56%
- Bipolar Disorder (mood disorder): 4 people, 6.56%
* Approximation only. Some reports may have incomplete information.
Do you take Vyvanse and Estradiol?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Vyvanse and Estradiol:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Vyvanse:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Estradiol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vyvanse and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Estradiol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on lisdexamfetamine dimesylate and estradiol (the active ingredients of Vyvanse and Estradiol, respectively), and Vyvanse and Estradiol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Sumatriptan cause Acne Aggravated? - 7 seconds ago
- Drug interactions of Crestor and Temaz - 14 seconds ago
- Could Victoza cause Balance Disorder? - 15 seconds ago
- Could Celebrex cause Lichenoid Keratosis? - 15 seconds ago
- Could Amlodipine cause Hallucination, Visual? - 25 seconds ago
- Could Tykerb cause Vertebral Foraminal Stenosis? - 34 seconds ago
- Could Glipizide cause Postoperative Wound Infection? - 38 seconds ago
- Could Cilostazol cause Nausea And Vomiting? - 44 seconds ago
- Drug interactions of Metoprolol Tartrate and Magnesium Glycinate - 52 seconds ago
- Could Gocovri cause Gait Disturbance? - 57 seconds ago